Results 291 to 300 of about 75,785 (301)

Role of CD19 Signal Transduction in B Cell Biology

Immunologic Research, 2002
Yue Wang
exaly  

CD19 Chimeric Antigen Receptor T-Cell Therapy

Grace A. Johnson, Michael D. Jain, Frederick L. Locke   +2 more
openaire   +1 more source

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies

Journal of Cellular and Molecular Medicine, 2016
Gesine Bug, Erhard Seifried, Winfried S Wels   +2 more
exaly  

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Molecular Therapy, 2018
Carlos A Ramos, Rayne H Rouce, Birju Mehta   +2 more
exaly  

Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions

Molecular Therapy - Methods and Clinical Development, 2019
Maria Castella, Miguel Caballero, Berta Marzal   +2 more
exaly  

Regulation of Antigen Receptor Signaling by the Co-Receptors, CD19 and CD22

2004
LARS NITSCHKE, DOUGLAS T. FEARON
openaire   +1 more source

CD19 as an attractive target for antibody-based therapy

MAbs, 2012
exaly  

Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.

Journal of Experimental Medicine, 1993
exaly  

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Cell
exaly  

An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Cell
exaly